Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Did you spell “perpose” on purpose?
I mean that article is crap. All that should be looked at are the actual outcome studies. To be fair, I don’t think serious people invest on those articles. A lot of weird charades in finance, I still think amarin is just a wait and hold play. Paul Choi still made a PT of $5 so who knows why people are selling on his note
If this was a thing wouldn’t everyone be buying shares for a quick 100% return? Makes no sense. $10 would get the company now in a heartbeat, I’m not sure if you’re trying to give good or bad advice.
2 years ago people on this board were saying “make sure we don’t accept anything under $100, $35 is a rip off!”
Your mouth to gods ears my friend
Sell target 10% above current value. Makes sense to me!!!
This article is 8 months old
No. That was their target assuming amarin won the court case, which I believe is very wrong. It was Oppenheimer who made the predictions and they’re a 4th tier “firm” at best
I assume they meant baker brother only. I don’t believe they had offers either, nor do I believe anyone on board would/will be privy to the info when it comes about. Even in the hedge fund world we verrry rarely know if there are buyout talks. If there are, the stock will soar and stay elevated if people feel it’s legit. There’s a lot of money to be thrown around on Wall Street for a “sure thing.” We all underestimated the challenges amarin would face. We got the science right, real world wrong
Makes sense then. I am praying for 5b at this point... I don’t want to sell my shares I have left, but it’s so dead money and the market is hot. Unfortunately it’s the drug of a lifetime that can’t sell. Even GV and V are nowhere near the numbers they should be.
Lowball? That’s 130% over current price. Don’t think that’s a lowball. Retail value always succumbs to street value. Until people believe this is worth $10 a share enough to put their money where their mouth is, it’s not. Not justifiable cash flow wise, sales growth wise, etc. We need a big court win or a big outside of US bump to get to that value
Totally agree. Seems like US is pretty much drained of value. Company needs to monetize Europe and Asia to get back to low double digits. I’ll take a 100%+ return in 2 years!
I’m not really sure what those charts mean. I have no idea how to tell where stocks will go or when. If I did, or was decent, I’d be worth 5 trillion dollars.
I’m just always surprised people know where stocks are going when no hedge funds or prop shops have any idea. I have 4 super computers working for me at work, and I have trouble figuring out what’s going to happen on micro second intervals. Longer term than that, mathematically, is almost impossible.
I guess you guys know better, I nor my industry have the abilities
By when? $4 next week? Or do you just say that because it went down today and there’s no reasoning?
Hm I guess, don’t think it closed that high. Either way, we’ve really been around 5-6.5 since March 2020. Hopefully we do get to 8-9, but again, we aren’t more equipped to make guesses than the market it. Everything we know, it does so things should be priced in
Haven’t seen $9 in over a year and everything is already pretty public...I hope you’re right though!
If this goes to $2, we’ll be drinking Charles Shaw wine...
Yeah. And also to get joe Biden and Donald trump to stand behind fauci, holding hands, while fauci says vascepa is a more important breakthrough than the covid vaccine.
Yeah I get that. If you want to invest in good drugs, unfortunately the safest bet is buying generic drug companies. Amarin is a $30 stock in drug greatness and a $1 stock in drug exclusivity at this point...we’ll see which one we end up closer to. Definitely more upside than downside, but gotta just not look at the price for a few months/ years
It’s either going to settle at $2 or $10 and a buy out long term. If you don’t like 50c price moves probably not a great company to be invested in.
We’re up 30% from end of March beating last year, dow. 70% from the day before that. These small moves mean nothing really if you’re an investor. If you’re a day trader then you shouldn’t care up or down.
Based on the stock volatility it’s expected to move 4% a day so this isn’t too weird
Failing to disappoint is a good thing though...so not sure if you’re happy about it or not
That’s warehousing and trading against customer flow. They can face and take risk vs customers (otc and listed). But they cannot prop trade.
At a lot of banks, trading revenue comes from 2 places- their own PWM arms that solely feed them the flow, and commissions, which their customers pay them for facilitation.
Knowing about a secondary and selling ahead of it is frontrunning and illegal. It’s trading on NPI
Prop desk? Have you heard of Dodd Frank? Banks don’t have prop desks.
Can you show me examples of where it’s done all the time? I’m just not familiar with how common it is. Every now and then I see a fine for front running but never for front running a secondary.
Gs didn’t buy any shares they sold them to their customers. So why would they short the stock? Also, that would be illegal and they can’t do that? You can see their holdings and shorts to verify your claim if you want though. Why would Goldman short it and screw their customers when banks make most of their money on share offerings and customer deals??
Ha remember when everyone was mad when amarin raised money in the teens....
Ha you think it’s the same guy who sold Nasdaq down 1.5% preopen?
What about 19.9??
They’re doing it at cost, they make enough overcharging everything else...
Why does everyone think Monday there will be fireworks? All the news out of the EU was out in early trading hours Friday, just curious if anything has changed since then?
Hasn’t this been a layup the whole time?
Why do you think that?
Now let’s normalize this to the last few surveys we did to adjust for high or low bias
Matinas is a very small company. Easy to move up or down 30%+ in a day. Amarin is 5x the market cap even after the recent convergence. The reality is, people only care about the US market. Big funds don’t care about ROW upside much since margins are lower and regulations are not as transparent
I’m not happy about it. But that’s the grim reality I see unfort
I think 5b+ would happen tbh. If anyone big believes this is undervalued or “wants the shares cheap” like everyone always says, there’s more than enough opportunity. Market thinks we’re worth 4-7 right now it seems. So maybe we can get 5-6b. No ones paying 15b for this any time soon
There were BO offers? When?
The larger the market cap the less likely a super high BO multiple. When amarin was $20, very unlikely more than 2x. Now, I think 3x or so is in the cards (still a 2b company, but cash is cheap now)
I think they were looking at pre approval numbers and growth, which technically is fair for them to compare to (although the results of RIT were known and that was a main impetus for increase in sales)
He says he’s already taking it, right?
Posted this elsewhere just now, but 500m companies can’t afford superstar CEOs. Imagine if we got someone who we paid 50m a year! How upset would the board be then even if all this did work out. JT took the same risks we all did in amarin, and he got hurt like us. I agree they are not the most experienced or best optical management team, but that’s out of a small company like amarins price range to be honest, unless you get really lucky
I know he’s CEO...but remember, he joined as CEO of a 500m company. Basically an average Silicon Valley startup, pre ipo. I agree a Fortune 500 CEO is better spoken, more aggressive making deals, etc. But those guys also make 20-200m a year. That was 5-50% of our market cap.
Amarin was a fighter. They believed they would win the court case and then easily get bought for 35+ (or some high number) or build out to selling 10b a year of vascepa. But none of them had ever done that before, been through such litigious battles, or grown a company from small to an 8b market cap. Honestly, if amarin did evolve into a 50b company, I’m sure JT would have eventually been replaced. But in the business scheme of things, everything happened so fast. They dropped hints here and there about bringing in outside counsel for BO or EU partnerships, but never seemed to seal any deals.
In the end of the day, we all won and made the right call. The drug works, it can be a 10b+ market, and the MOA. But the unknowns are where we got hurt. We were all exorbitant and had bias. Lawyers who said our chances were 50/50 for the first trial we all dismissed and said they were spreading FUD. Maybe they were, but they were also right this wasn’t a shoe in. Hikma and teddy are constantly fighting legal battles like this. Company is prepped, team is experienced, everything is streamlined. Sucks the good guys lost. Obviously the justice system can be duped, and we were on the losing side